期刊： ADVANCES IN RHEUMATOLOGY, 2021; 61 (1)
Objectives To investigate the diagnostic performance of single-source dual-energy computed tomography (DECT) based on gemstone spectral imaging techno......
期刊： ADVANCES IN RHEUMATOLOGY, 2021; 61 (1)
Objectives To explore the risk factors for systemic lupus erythematosus (SLE) flare and their impact on prognosis. Methods The clinical characteristic......
期刊： ADVANCES IN RHEUMATOLOGY, 2021; 61 (1)
BackgroundOsteoarthritis (OA) is defined as a degenerative disease. Pivotal roles of long non-coding RNA (lncRNAs) in OA are widely elucidated. Herein......
期刊： ADVANCES IN RHEUMATOLOGY, 2021; 61 (1)
Backgrounds It is important to improve our understanding of the roles of calcium and vitamin D in bone health for preventing osteoporosis. We aimed at......
期刊： ADVANCES IN RHEUMATOLOGY, 2021; 61 (1)
Background: Hyperhomocysteinemia is associated with autoimmune diseases such as ankylosing spondylitis (AS), systemic lupus erythematosus (SLE), and r......
期刊： ADVANCES IN RHEUMATOLOGY, 2020; 60 (1)
Objective Gout is characterized by inflammatory arthritis with hyperuricaemia and deposition of monosodium urate (MSU) crystals in the joints. Several......
期刊： ADVANCES IN RHEUMATOLOGY, 2020; 60 (1)
Background Anti-ribosomal P (anti-Rib-P) antibody is a specific serological marker for systemic lupus erythematosus (SLE) and routinely tested by targ......
期刊： ADVANCES IN RHEUMATOLOGY, 2022; 62 (1)
Objective The objective was to evaluate whether initiation of urate-lowering treatment (ULT) during an acute gout flare prolonged the current episode.......
期刊： ADVANCES IN RHEUMATOLOGY, 2022; 62 (1)
Objectives To describe the feature of expression of syndecan-4 in serum, synovial fluid (SF) and synovium in rheumatoid arthritis (RA) patients, and t......
期刊： ADVANCES IN RHEUMATOLOGY, 2022; 62 (1)
Background Interstitial lung disease (ILD) is a common pulmonary complication of connective tissue disease (CTD). This study aims to evaluate the clin......
期刊： ADVANCES IN RHEUMATOLOGY, 2022; 62 (1)
Background Statins have long been extensively prescribed as effective lipid-lowering agents, but statins have also been recognized as novel immunomodu......
期刊： ADVANCES IN RHEUMATOLOGY, 2022; 62 (1)
Background Systemic lupus erythematosus (SLE), a chronic systemic autoimmune disease, often affects different organs and tissues. It can be effectivel......
期刊： ADVANCES IN RHEUMATOLOGY, 2022; 62 (1)
Background Phospholipase C-like 1 (PLCL1), a protein that lacks catalytic activity, has similar structures to the PLC family. The aim of this research......
期刊： ADVANCES IN RHEUMATOLOGY, 2022; 62 (1)
Background Pulmonary hypertension (PH) is a frequent complication of systemic sclerosis (SSc) and is currently one of the primary causes of death in p......
